Key facts
- It has raised $40K; the latest was Later Stage VC in Jan 2026.
- Notable investors include Innovate UK, Techstart Ventures, Mayo Clinic Platform, Duncreggan Student Village, Enterprise Hub - Royal Academy of Engineering — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for PulseAI
- ·The full record, as it builds
Funding rounds
No funding rounds for PulseAI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PulseAI
Developer of an artificial intelligence-powered heart screening software designed to improve the accuracy, efficiency, and scalability of cardiac diagnostics. The company's software provides an automated analysis of long-term electrocardiogram recordings from wearable devices, which are then stored in a proprietary internal database containing highly specialised and diverse data, enabling patients to avail improved cardiac diagnosis.
- Sector
- Healthcare
- HQ
- Belfast, United Kingdom
- Employees
- 10
- Website
- pulseai.io/
- Ownership
- Privately Held (backing)
PulseAI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PulseAI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PulseAI in its N-PORT filings yet. We sweep new filings monthly.